Precision medicine for managing diabetes.
作者信息
Klonoff David C
机构信息
Mills-Peninsula Health Services, San Mateo, CA, USA
出版信息
J Diabetes Sci Technol. 2015 Jan;9(1):3-7. doi: 10.1177/1932296814563643.
Abstract
摘要
相似文献
1
Precision medicine for managing diabetes.糖尿病管理的精准医学
J Diabetes Sci Technol. 2015 Jan;9(1):3-7. doi: 10.1177/1932296814563643.
2
Primary central nervous system lymphoma: Novel precision therapies.原发性中枢神经系统淋巴瘤：新型精准治疗方法。
Crit Rev Oncol Hematol. 2019 Sep;141:139-145. doi: 10.1016/j.critrevonc.2019.06.009. Epub 2019 Jun 27.
3
Mapping the Mutation Landscape of Colorectal Cancer.绘制结直肠癌的突变图谱
Am J Med Sci. 2019 Nov;358(5):313-314. doi: 10.1016/j.amjms.2019.08.004. Epub 2019 Aug 14.
4
Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.精准医学的定义：精准医学计划的NCI-MPACT和NCI-MATCH试验。
Curr Probl Cancer. 2017 May-Jun;41(3):182-193. doi: 10.1016/j.currproblcancer.2017.02.001. Epub 2017 Feb 11.
5
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.基于肿瘤分子图谱的治疗算法：精准医学试验的本质
J Natl Cancer Inst. 2015 Nov 23;108(4). doi: 10.1093/jnci/djv362. Print 2016 Apr.
6
Personalized medicine in diabetes mellitus: current opportunities and future prospects.糖尿病个性化医疗：当前机遇与未来前景
Ann N Y Acad Sci. 2015 Jun;1346(1):45-56. doi: 10.1111/nyas.12757. Epub 2015 Apr 23.
7
Pediatric oncology enters an era of precision medicine.儿科肿瘤学进入了精准医学时代。
Curr Probl Cancer. 2017 May-Jun;41(3):194-200. doi: 10.1016/j.currproblcancer.2017.01.002. Epub 2017 Feb 1.
8
Precision medicine in diabetes prevention, classification and management.糖尿病预防、分类和管理中的精准医学。
J Diabetes Investig. 2018 Sep;9(5):998-1015. doi: 10.1111/jdi.12830. Epub 2018 Apr 25.
9
Preparing pathology for precision medicine: challenges and opportunities.为精准医学准备病理学：挑战与机遇
Virchows Arch. 2017 Aug;471(2):141-146. doi: 10.1007/s00428-017-2141-z. Epub 2017 May 16.
10
Precision Medicine and Targeted Therapies in Breast Cancer.精准医学与乳腺癌的靶向治疗
Surg Oncol Clin N Am. 2020 Jan;29(1):51-62. doi: 10.1016/j.soc.2019.08.004. Epub 2019 Oct 29.
引用本文的文献
1
Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Editors' Expert Forum.单基因糖尿病：从遗传认识到基于人群的精准医疗。编辑专家论坛的思考。
Diabetes Care. 2020 Dec;43(12):3117-3128. doi: 10.2337/dci20-0065.
2
Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM.果糖胺-3-激酶在预防 T2DM 患者微血管和大血管并发症中的作用。
BMJ Open Diabetes Res Care. 2020 May;8(1). doi: 10.1136/bmjdrc-2020-001256.
3
Characterizing the weight-glycemia phenotypes of type 1 diabetes in youth and young adulthood.描述青少年和青年期1型糖尿病的体重-血糖表型。
BMJ Open Diabetes Res Care. 2020 Jan;8(1). doi: 10.1136/bmjdrc-2019-000886.
4
The Need for Precision Medicine to be Applied to Diabetes.精准医学在糖尿病中的应用需求。
J Diabetes Sci Technol. 2020 Nov;14(6):1122-1128. doi: 10.1177/1932296819894295. Epub 2020 Jan 6.
5
Digital Health Interventions for Diabetes: Everything to Gain and Nothing to Lose.糖尿病的数字健康干预措施：只有收获，没有损失。
Diabetes Spectr. 2019 Aug;32(3):226-230. doi: 10.2337/ds18-0085.
6
Precision Diabetes Is Slowly Becoming a Reality.精准糖尿病治疗正逐渐成为现实。
Med Princ Pract. 2019;28(1):1-9. doi: 10.1159/000497241. Epub 2019 Jan 27.
7
Digital Diabetes Data and Artificial Intelligence: A Time for Humility Not Hubris.数字糖尿病数据与人工智能：是谦逊而非傲慢的时候了。
J Diabetes Sci Technol. 2019 Jan;13(1):123-127. doi: 10.1177/1932296818796508. Epub 2018 Sep 5.
8
Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications.持续葡萄糖监测：在糖尿病管理中的当前应用及未来可能的应用
J Diabetes Sci Technol. 2018 Sep;12(5):1064-1071. doi: 10.1177/1932296818774078. Epub 2018 May 22.
9
Finding Real Value From Digital Diabetes Health: Is Digital Health Dead or in Need of Resuscitation?从数字糖尿病健康中寻找真正价值：数字健康是已死还是需要复苏？
J Diabetes Sci Technol. 2018 Sep;12(5):911-913. doi: 10.1177/1932296818771200. Epub 2018 May 3.
10
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?天然产物对 Nrf2 信号通路的激活作用——能缓解糖尿病吗？
Biotechnol Adv. 2018 Nov 1;36(6):1738-1767. doi: 10.1016/j.biotechadv.2017.12.015. Epub 2017 Dec 28.
本文引用的文献
1
From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.从分子特征到预测性生物标志物：疾病病理生理学和药物作用机制的建模。
Front Cell Dev Biol. 2014 Aug 22;2:37. doi: 10.3389/fcell.2014.00037. eCollection 2014.
2
Informatics tools to advance the biology of glycosaminoglycans and proteoglycans.推动糖胺聚糖和蛋白聚糖生物学研究的信息学工具。
Methods Mol Biol. 2015;1229:271-87. doi: 10.1007/978-1-4939-1714-3_23.
3
Managing, analysing, and integrating big data in medical bioinformatics: open problems and future perspectives.医学信息学中大数据的管理、分析与整合：开放问题与未来展望
Biomed Res Int. 2014;2014:134023. doi: 10.1155/2014/134023. Epub 2014 Sep 1.
4
Big data: survey, technologies, opportunities, and challenges.大数据：调查、技术、机遇与挑战。
ScientificWorldJournal. 2014;2014:712826. doi: 10.1155/2014/712826. Epub 2014 Jul 17.
5
Metformin pharmacogenomics: current status and future directions.二甲双胍药物基因组学：现状与未来方向。
Diabetes. 2014 Aug;63(8):2590-9. doi: 10.2337/db13-1367.
6
Data mining for identifying novel associations and temporal relationships with Charcot foot.数据挖掘以识别与夏科氏足的新型关联和时间关系。
J Diabetes Res. 2014;2014:214353. doi: 10.1155/2014/214353. Epub 2014 Apr 27.
7
Precision medicine for nurses: 101.护士的精准医疗：基础入门
Semin Oncol Nurs. 2014 May;30(2):84-99. doi: 10.1016/j.soncn.2014.03.002.
8
Precision medicine--delivering the goods?精准医学——能实现预期效果吗？
Cancer Lett. 2014 Sep 28;352(1):2-3. doi: 10.1016/j.canlet.2014.04.011. Epub 2014 Apr 24.
9
Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus.PPARγ-2、ACE、MTHFR、FABP-2 和 FTO 基因遗传多态性与 2 型糖尿病发病风险的关联。
J Biomed Sci. 2013 Oct 25;20(1):80. doi: 10.1186/1423-0127-20-80.
10
The potential of novel biomarkers to improve risk prediction of type 2 diabetes.新型生物标志物提高 2 型糖尿病风险预测的潜力。
Diabetologia. 2014 Jan;57(1):16-29. doi: 10.1007/s00125-013-3061-3.
Zotero 插件